Translate page

Mount Kilimanjaro has been climbed. CML can be cured.

IMG 20191104 WA0002 Mount Kilimanjaro has been climbed! In 2019 the iCMLf undertook a unique charity challenge to raise funds for the iCMLf CURE CONSORTIUM The funds raised will play an integral role in getting closer to a cure for CML. An amazing team of 26 climbers – researchers, doctors, patients and supporters from all over the world raised over $300,000 for the work of the Foundation. From 26 October to 3 November the Climb for a cure team sucessfully climbed Mount Kilimanjaro. The youngest climber was 18 years old, a CML patient from Germany.

$304,464 total funds raised by the Climb for a Cure team

26 participants from all over the world including Africa, Australia, Europe, Middle East, South America and USA

Click here to see our Climb for a Cure Mount Kilimanjaro video

Timothy HughesThe iCMLf CURE CONSORTIUM

Concerted global effort working towards a cure for CML

"There are currently estimated to be over 800,000 CML patients globally. CML is predicted to become the most prevalent leukaemia by 2040 when there are projected to be over 3 million patients worldwide. A concerted global effort working towards a cure is imperative.
The iCMLf is uniquely positioned to drive this effort.” 
(Tim Hughes, iCMLf Chairman)

With the increasing prevalence of CML a concerted global effort working towards a cure is imperative. As a global organisation led by clinicians and researchers at the forefront of this disease, the iCMLf is uniquely positioned to do this. The iCMLf is increasingly turning to global priorities through precision medicine approaches aiming to improve outcomes for patients with CML.

The iCMLf will drive this effort by bringing interested parties together on specific projects under the banner of 'cure'. The Foundation has formed a CURE CONSORTIUM to focus our efforts working towards a cure for CML. Specifically, we plan to build multicentre global research collaborations to accelerate the development of more effective and safer treatment strategies with the view that these will lead to a cure.

 DSC3214 KopieAlliance 1: The iCMLf Genomics Alliance

Developing a genome-based risk-calculator for newly diagnosed CML patients

The iCMLf has formed a Genomics Alliance to develop a genome-based risk calculator for newly diagnosed CML patients. The Alliance aims to harness the wealth of genomic information that is generated in local CML research projects by building a platform to facilitate data assimilation and sample exchanges. Combining many data sets and facilitating global collaborative studies will enable us to develop a baseline predictor of adverse outcomes.

 DSC3463 KopieAlliance 2: The iCMLf TFR Alliance

Maximising achievement of TFR while minimising failed TFR attempts and other negative outcomes

The iCMLf has recently launched a second Alliance under the banner of CURE - the iCMLf Treatment-Free-Remission (TFR) Alliance. The mission of the iCMLf TFR Alliance is to maximise achievement of TFR while minimising failed TFR attempts and other negative outcomes.

20191030 094753

The iCMLf Climb for a Cure Mount Kilimanjaro 2019 Diary

Follow us on our way to the summit and experience with us all the challenges and wonderful experiences along the way

Our Climb for a Cure Mount Kilimanjaro video perfectly illustrates what the Climb for a Cure 2019 means to all of us, but especially for patients with CML.
Click here to see the video.


The Climb for a Cure Corporate sponsors

Just like on the mountain we would not have been so successful without a strong team. We are very grateful for all the support we received in the past year – from all our climbers who worked so hard to raise funds and to prepare for the climb and from every single person who supported us with their donations - among them an anonymous donation of $ 100,000.

We acknowledge all of our corporate sponsors for their generous support: